text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 31637-97-5 | Product Number: E1359

Etofibrate


Purity: >98.0%(GC)
Synonyms:
  • 2-[2-(4-Chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl 3-Pyridinecarboxylate
  • 3-Pyridinecarboxylic Acid 2-[2-(4-Chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl Ester
  • 2-[[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy]ethyl Nicotinate
  • Nicotinic Acid 2-[[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy]ethyl Ester
Product Documents:
50MG
$157.00
Contact Us Contact Us 8  
250MG
$549.00
Contact Us Contact Us 14  

* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.


Product Number E1359
Purity / Analysis Method >98.0%(GC)
Molecular Formula / Molecular Weight C__1__8H__1__8ClNO__5 = 363.79 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Condition to Avoid Heat Sensitive
CAS RN 31637-97-5
Reaxys Registry Number 497931
PubChem Substance ID 468591729
Merck Index (14) 3877
MDL Number

MFCD00865727

Specifications
Appearance White to Almost white powder to crystal
Purity(GC) min. 98.0 %
Melting point 48.0 to 52.0 °C
NMR confirm to structure
Properties (reference)
Melting Point 50 °C
Boiling Point 214 °C/0.3 mmHg
GHS
Related Laws:
Transport Information:
HS Number 2933.39.4100
Application
Etofibrate: A Hybrid Hypolipidemic Agent which Combines Nicotinic Acid (Niacin) with Clofibrate

Etofibrate is a hypolipidemic fibrate which combines nicotinic acid (niacin) [N0082] with clofibrate [C0941]. After contact with plasma hydrolases, both active constituents are gradually released in a controlled-release manner. The fibrates, including etofibrate, are lower elevated serum lipids by decreasing the low density lipoprotein (LDL) fraction rich in cholesterol and the very low density lipoprotein (VLDL) fraction rich in triglycerides. In addition, fibrates increase the high density lipoprotein (HDL) cholesterol fraction. (The product is for research purpose only.)

References


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.